BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 19, 2026
Home » Authors » Nuala Moran

Articles by Nuala Moran

University Of Glasgow, Pharmetix Join Together To Start Grannus

Feb. 25, 2004
By Nuala Moran

Domantis Plans dAbs Trials With £17.5M In Second-Round Funds

Feb. 25, 2004
By Nuala Moran

Domantis Plans dAbs Trials With £17.5M In Second-Round Funds

Feb. 25, 2004
By Nuala Moran

University Of Glasgow, Pharmetix Join Together To Start Grannus

Feb. 25, 2004
By Nuala Moran

GeneMedix Considers Merger, Plans U.S. Listing On Nasdaq

Feb. 18, 2004
By Nuala Moran

Ark To Test London's IPO Waters With £55M Offering

Feb. 18, 2004
By Nuala Moran
LONDON - Ark Therapeutics Group Ltd. has confirmed plans for an initial public offering to raise £55 million (US$104.7 million), a move that will be followed closely by those at cash-starved companies across Europe who are waiting for the IPO window to open. (BioWorld International)
Read More

Ark To Test London's IPO Waters With £55M Offering

Feb. 18, 2004
By Nuala Moran
LONDON - Ark Therapeutics Group Ltd. has confirmed plans for an initial public offering to raise £55 million (US$104.7 million), a move that will be followed closely by those at cash-starved companies across Europe who are waiting for the IPO window to open. (BioWorld International)
Read More

GeneMedix Considers Merger, Plans U.S. Listing On Nasdaq

Feb. 18, 2004
By Nuala Moran

Ark Seeks Listing On London Stock Exchange Via £50 IPO

Feb. 11, 2004
By Nuala Moran
LONDON - Ark Therapeutics Group plc is feeling out investor appetite for what would be the first listing of a biotechnology company on the main market of the London Stock Exchange in three years. (BioWorld International)
Read More

CAT Reports CAT-192 Results With Genzyme, Ends Elan Deal

Feb. 11, 2004
By Nuala Moran
Previous 1 2 … 454 455 456 457 458 459 460 461 462 … 531 532 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing